Please Note: Delivery will be delayed by a few days due for a scheduled holiday break, 03 Mar 2026 to 07 Mar 2026.
We apologize for any inconvenience and will prioritize your shipment as soon as we return.
We apologize for any inconvenience and will prioritize your shipment as soon as we return.
Cagrilintide + Semaglutide (5mg + 5mg)
- Name: CS10 Peptide Blend
- Components: 5mg Cagrilintide + 5mg Semaglutide per vial
- Quantity: 10 mg total (lyophilised powder)
- Formulation: Dual‑peptide lyophilised blend
Key Features
- Purity: ≥ 98.0% (HPLC‑verified)
- Endotoxin: ≤ 5 EU/mg
- Form: Freeze‑dried (lyophilised) powder for stability
- Documentation: Certificate of Analysis (COA) supplied with every lot
Peptide Information
- Cagrilintide (5mg):
- Amylin analog peptide
- Investigated for appetite regulation and satiety signaling
- Semaglutide (5mg):
- GLP‑1 receptor agonist peptide
- Studied for glycemic control and weight management
Storage & Stability
- Long‑term: –20 °C, dry and desiccated
- Short‑term: Stable at 2–8 °C
- Handling Note: Avoid repeated freeze–thaw cycles
Intended Use
- For laboratory research only
- Not for human or veterinary use
- Not approved for diagnostic, therapeutic, or medical applications
- Must be handled using appropriate laboratory safety practices
Why Choose CS10 (5mg + 5mg)?
- Dual‑peptide synergy for advanced metabolic research
- High purity suitable for sensitive experimental systems
- Full batch traceability with COA included
- Lyophilised for extended shelf stability
| Weight | 20 g |
|---|---|
| Dimensions | 1 × 1 × 3 cm |
